|
05/23/2011
Authored by John Barnes, for the Council on Foundations
FCAA and many of our partners in the philanthropy community mobilize
philanthropic leadership, ideas, and resources, and seek opportunities
for collaboration, including public-private partnerships. This work is
as challenging as it is important, but now the philanthropic sector has a
new and engaged partner in the federal government: the Social Innovation Fund (SIF).
Read the full blog on re:Philanthropy
Read more.
|
|
04/12/2012
Download the slides!
Read more.
|
|
04/24/2012
Authored by Owen Ryan, Deputy Director, Public Policy at amfAR
At a community meeting in Atlanta, Georgia on March 20th, Kevin Fenton, director of Centers for Disease Control & Prevention’s (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention said, “Our own stigma, our own homophobia, cascades down in our funding and allocations…” Dr. Fenton was recognizing a reality in the United States that has become increasingly apparent to health policymakers throughout the world: that despite high prevalence rates of HIV among gay men and other MSM, funding for HIV prevention, treatment and care consistently neglects these populations, often due to stigma and discrimination...
Read more.
|
|
04/24/2012
Authored by Sean Cahill, Director, Health Policy Research, Fenway Institute
Over the past few years we have witnessed a number of advances in science-based HIV prevention and care policy and LGBT health policy in the U.S. We have a first-ever National HIV/AIDS Strategy that prioritizes reducing the disparity affecting gay and bisexual men—who were 64% of new infections in 2009, although just 2% of the adult population. We repealed a number of counterproductive policies dating back to the dark days of the 1980s and Senator Jesse Helms, such as ending the HIV entry ban, ending the ban on using federal funds for syringe exchange, and ending funding for abstinence-only-until-marriage education. Unfortunately, the latter two changes were short-lived. And we’ve seen long overdue increases in funding for Ryan White care, the AIDS Drug Assistance Program, HIV prevention through the CDC, and research at NIH, including promising biomedical prevention research....
Read more.
|